商品编号


JP10415



品牌


IBL



公司


IBL,inc



公司分类


Immunology / Cytokines


商品信息

Quantity / Tests
100?g
Species / Antigen
Synthetic peptide (CMQSGP
KPL
FRRMSS)
Host
Mouse
Subclass / Clone
IgG3/4-6H:2C
Type
Monoclonal
Purification
Protein A
Label
No
Regulatory Status:
For research use only


Details for:


?
Anti-human CD20 (N) (4-6:2C) Mouse IgG

Rituximab used for treatment of lymphoma is an antibody drug targeting CD20. It has been reported that the C-terminal region of CD20 undertakes a critical role in binding to rituximab and the association between C-terminal mutations and rituximab-resistance has been investigated. This antibody was developed as a new monoclonal antibody that recognizes the N-terminal region of CD20 molecule to detect comprehensive CD20 regardless of C-terminal mutations. It is expected to be useful for the detailed examination of CD20 molecules by adding this antibody to research CD20.

For concrete data please consult the Instruction for Use in the download box on the right side.